TrialCancer chemotherapy and pharmacology2014

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.

Yee Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.